Although the Ministry of Food and Drug Safety (MFDS) ordered a license revocation on Medytox’ botulinum toxin drugs, they would be back on the shelf and available for sales as the court halts the administrative action. The relevant industry insiders are pointing out MFDS should be more thorough with pre-sales lot release approval for the people’s health and safety.

In late 2019, MFDS ordered the company to shorten the expiration date due to safety issues, and imposed an item approval revocation on Meditoxin in June 2020, when it was found to have used unapproved ingredient and manipulated submitted national lot release review material. The ministry also revoked the license on a liquid type botulinu